Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine with Botulinum Toxin for Focal Dystonia
NCT00015457Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Apr 2001
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of amlodipine in cervical dystonia (CD), sponsored by National Institute of Neurological Disorders and Stroke. Primary endpoint: Toronto Western Spasmodic Torticollis Rating Scale Sum Score. Started Apr 2001; status: completed.
02
Drugs
amlodipine
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on NCT00015457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00015457.